Homeopathics Reap Rewards From Sowing Fields For Success – Hyland's CEO
This article was originally published in The Tan Sheet
Hyland's and other homeopathic remedy firms did not expect quality control problems at the most well known OTC drug to drive growth for the homeopathic sector.
You may also be interested in...
Matrixx Initiatives’ troubled history with FDA continues with a warning two of its products are unapproved new drugs because they combine supplements with OTC drugs.
Johnson & Johnson's OTC drug recalls are driving interest in homeopathic remedies and other alternative health products, experts and stakeholders say.
Leading OTC drug firms will voluntarily expand the use of child-resistant packaging to all cough/cold products while also considering new child-proof package designs to reduce the risk of accidental ingestion, the Consumer Healthcare Products Association says